Chonluten Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Chonluten dosing — protocols, safety, and where to buy.
Dose Range
10 mg oral capsule, 1-2 daily for 10-30 days
Dosage Calculator
Calculate exact dosing for Chonluten.
Dosing Protocols
Beginner Chonluten Protocol (first respiratory cycle)
- Product form: 20 mg oral capsule from vendor with third-party HPLC. Decide between polypeptide extract (original form) and synthetic EDG tripeptide (preferred for users with animal protein allergy concerns).
- Dose: 1 capsule (20 mg) once daily, sublingual (dissolve under tongue ~60 seconds) or oral on empty stomach 30–45 min before breakfast.
- Duration: 10 consecutive days.
- Washout: 60 days before repeat.
- Timing: Autumn entry before winter respiratory season is Russian clinical convention.
- Monitoring: Home peak flow meter daily if available, subjective dyspnoea VAS (0–10), cough frequency, sputum character.
- Continue inhalers if prescribed. Do not substitute Chonluten for maintenance inhaled therapy.
- Stop criteria: Worsened dyspnoea, new wheeze, rash, persistent headache, new respiratory symptom.
- Expectations: Modest subjective effect at best. If moderate-severe COPD on inhalers, do not expect Chonluten to replace them.
- Avoid extract form if animal protein allergy. Synthetic EDG is the conservative choice in that setting.
Intermediate Chonluten Protocol (experienced bioregulator user)
- Product form: 20 mg oral (extract or synthetic EDG) or lyophilised synthetic EDG peptide for reconstitution.
- Dose: 20 mg oral daily OR 2–5 mg SC daily (synthetic form).
- Duration: 10 consecutive days per cycle.
- Cycling: Twice yearly — autumn and spring.
- Rotation: Alternate with Bronchogen AEDP or pair sequentially.
- Monitoring: Daily symptom diary, annual spirometry if COPD, peak flow tracking. Coordinate cycles with any planned clinic spirometry.
- Stack: Continue evidence-graded respiratory therapy. Chonluten is the experimental layer.
- Documentation: Cycle log with dose, source, lot, symptom scores.
- Expectations: Subjective effects remain modest. Some users report fewer winter respiratory infections; this could be real, placebo, or covariate.
- Cost: Annual Chonluten cycling 150–300 USD. Compare to air purifier, pulmonary rehab, or smoking cessation investment.
Advanced Chonluten Protocol (Khavinson respiratory rotation)
- Annual rotation:
- Month 1, Days 1–10: Chonluten 20 mg oral (synthetic EDG preferred) OR 5 mg SC daily.
- Months 2–3: Washout.
- Month 4, Days 1–10: Bronchogen 20 mg oral daily (parallel AEDP).
- Months 5–6: Washout.
- Month 7, Days 1–10: Thymogen 100 mcg SC or intranasal daily.
- Months 8–9: Washout.
- Month 10, Days 1–10: Chonluten repeat.
- Months 11–12: Washout.
- Monitoring: Baseline and annual spirometry (FEV1, FVC, FEV1/FVC, peak flow), annual chest imaging if indicated, CBC and CMP annually.
- Stack on evidence-graded base: Inhalers continued, smoking cessation achieved, vaccinations up to date, pulmonary rehabilitation completed or ongoing. Bioregulator is the experimental add-on.
- Pulmonology coordination. Notify pulmonologist of bioregulator cycles.
- Stop and reassess if new respiratory symptoms, worsened spirometry beyond expected age-related decline, or unexpected effects. Maintain evidence-graded foundation.
- Realistic expectation: Advanced protocol is a ritual on top of sound respiratory care. Users cannot reliably distinguish bioregulator effect from concurrent improvements in exercise, smoking status, or environmental exposures.
Commonly Stacked With
Stacking Notes
Khavinson rotation
Chonluten cycles alongside Bronchogen, Thymogen, Epitalon, Pinealon, Vilon, Livagen, Cardiogen, and Cartalax in community multi-bioregulator rotations.
A respiratory-focused rotation might run:
- Days 1–10: Chonluten 20 mg oral daily OR Chonluten polypeptide extract as labelled
- Days 11–70: Washout
- Days 71–80: Bronchogen 20 mg oral daily (parallel respiratory bioregulator)
- Days 81–140: Washout
- Days 141–150: Thymogen 100 mcg SC or intranasal daily (immune support)
- Days 151–210: Washout
- Days 211–220: Chonluten repeat
Chonluten + Bronchogen combined?
Community users sometimes combine Chonluten and Bronchogen in the same cycle or alternate between them. There is no evidence of harm from this combination at convention doses; there is also no evidence of synergy. Given functional overlap, combining both adds cost without clear benefit. If budget-constrained, pick one.
Evidence-graded respiratory stack (preferred)
- Smoking cessation — nothing else matters nearly as much.
- Pulmonary rehabilitation.
- Inhaled bronchodilators (SABA PRN, LABA/LAMA maintenance).
- Inhaled corticosteroids when indicated.
- Vaccinations.
- NAC 600–1200 mg daily for chronic bronchitis.
- Environmental air quality and allergen reduction.
- Biologics for severe asthma phenotypes.
- Weight management for obesity-related disease.
- Experimental bioregulators (Chonluten, Bronchogen) as tier-10 add-ons.
Stacking with inhaled therapy
No documented interactions. Continue inhalers during Chonluten cycles. Do not substitute.
Stacking with NAC
NAC 600–1200 mg daily plus Chonluten cycles is a common community pattern. No interaction concerns. NAC provides mucolytic effect plus glutathione precursor support.
Stacking with oral respiratory medications
Theophylline, leukotriene antagonists, PDE4 inhibitors, macrolides for chronic respiratory disease — no documented interactions. Continue guideline-directed therapy.
Contraindicated combinations
Do not substitute for smoking cessation. Do not delay antibiotic therapy for acute bacterial exacerbation. Do not replace biologics in severe asthma. Do not use as monotherapy in any diagnosed respiratory disease.
Side Effects & Safety
Contraindications
## Contraindications ### Absolute contraindications - **Pregnancy** — no reproductive toxicology data - **Breastfeeding** — no excretion/infant safety data - **Paediatric use (<18)** - **Active lung cancer or recent history** - **Active tuberculosis** — specific anti-TB therapy required - **Acute pneumonia or bacterial exacerbation** — appropriate antibiotic therapy required - **Known hypersensitivity** to Chonluten, any Khavinson bioregulator, or bovine/porcine protein (for extract form) - **Prion disease history or concern** (extract form) ### Relative contraindications (supervised use only) - **Severe COPD (GOLD 3–4, FEV1 <50%)** - **Pulmonary fibrosis** — evidence-graded antifibrotic therapy (nintedanib, pirfenidone) - **Pulmonary hypertension** - **Home oxygen therapy** - **Severe asthma on biologics** - **Recent solid organ transplant** - **Severe renal impairment (eGFR <30)** - **Decompensated hepatic disease** ### Use with caution - **Animal protein allergy** (beef, pork) — avoid extract form, synthetic EDG may be appropriate - **Multiple respiratory medications** (polypharmacy) - **Active smoker** — Chonluten does not substitute for cessation - **Occupational lung disease** ### Quality-of-supply contraindication Do not use Chonluten from vendors without third-party testing. For extract form, pathogen screening and sourcing documentation required. ### Symptoms requiring evaluation, not bioregulators New dyspnoea, haemoptysis, unexplained weight loss, night sweats, persistent cough over 3 weeks, fever, chest pain — prompt medical evaluation, not self-treatment.
Additional Notes
Dosage Notes
Oral/sublingual dosing (extract or synthetic capsule)
- 1 capsule (20 mg nominal) once daily
- Sublingual preferred, hold ~60 seconds
- Empty stomach 30–45 min before first meal
- Duration 10 days per cycle
- Washout 60–90 days
20 mg capsule = undisclosed actual peptide content (historically 2–4 mg for extract or synthetic form).
Subcutaneous dosing (synthetic EDG)
- 2–5 mg SC once daily
- 10 consecutive days per cycle
- 60-day washout
Do not inject polypeptide extract form subcutaneously without explicit vendor instructions — extract forms are typically intended for oral use only due to animal-tissue origin.
Intranasal dosing
Not a Khavinson convention for Chonluten. Some community experimenters attempt intranasal based on Semax/Selank precedent — no published protocol exists.
Cycling rationale
10-on / 60-off uniform Khavinson convention. Not empirically optimised for Chonluten specifically.
Seasonal timing
Autumn entry is Russian clinical convention, preceding winter respiratory virus season. Rationale is timing not empirically optimised.
Maximum dose
No established maximum. Do not exceed 20 mg oral or 5 mg SC daily without clinical reason.
Continuous dosing
Do not run continuous cycles.
Age considerations
Russian studies enrol older adults. No paediatric use.
Renal impairment
No formal dose adjustment. Avoid in eGFR <30.
Hepatic impairment
No formal dose adjustment. Avoid in decompensated hepatic disease.
Frequently Asked Questions
What is the recommended Chonluten dosage?
The typical dose range for Chonluten is 10 mg oral capsule, 1-2 daily for 10-30 days. Always start with the lowest effective dose.
How often should I take Chonluten?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Chonluten need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Chonluten side effects?
## Side Effects and Safety Chonluten short-term safety signal from Russian literature is mild. Long-term pharmacovigilance is effectively absent. ### Reported short-term adverse effects - **Gastrointestinal:** mild nausea, dyspepsia (oral form). Typically self-limited. - **Headache:** occasional mild headache. - **Fatigue or sleep:** variable. - **Rare allergic reactions:** occasional mild rash. Reports of allergic reactions are slightly higher for the polypeptide extract form than for the synthetic EDG tripeptide, likely reflecting immune recognition of bovine/porcine protein contaminants in the extract. - **No reports of paradoxical respiratory worsening** attributable to Chonluten. ### Theoretical concerns - **Animal protein allergy (extract form).** The polypeptide extract form contains low-molecular-weight fragments from bovine or porcine tissue. Patients with beef, pork, or animal-protein allergies should avoid the extract form. The synthetic EDG tripeptide does not have this concern. - **Prion disease risk (extract form, theoretical).** Historically, bovine-tissue-derived pharmaceuticals have been subject to scrutiny for BSE/CJD transmission risk. Modern pharmaceutical-grade manufacturing with appropriate sourcing (CJD-free herds, thorough processing) minimises this risk substantially, but not all post-Soviet supplement manufacturers meet Western pharmaceutical sourcing standards. - **Respiratory epithelium cancer risk.** Chonluten is claimed to promote epithelial regeneration, which theoretically overlaps with carcinogenic programmes in high-risk populations (current/former smokers, occupational exposures). Long-term oncology risk in these populations is unknown. - **Drug interactions.** No pharmacokinetic or pharmacodynamic studies with inhaled or oral respiratory drugs. ### Pregnancy and breastfeeding No reproductive toxicology data. Avoid. ### Paediatric use No paediatric safety data. Do not use. ### Active lung cancer Do not use in active lung cancer or recent history. Chromatin-modulation mechanism (if real) is inappropriate in proliferative disease of target tissue. ### Active respiratory infection Do not use as substitute for appropriate antimicrobial therapy in pneumonia, tuberculosis, or bacterial exacerbation. ### Advanced respiratory disease Severe COPD (FEV1 <30% predicted, GOLD 4), pulmonary fibrosis, pulmonary hypertension, home oxygen — work with pulmonologist, not with experimental bioregulators. ### Animal protein allergy Avoid polypeptide extract form if beef, pork, or animal protein allergy. Synthetic EDG tripeptide may be appropriate. ### Supply quality Require third-party testing. Extract form requires additional scrutiny for sourcing provenance and pathogen screening. ### Overall assessment Short-term signal mild. Long-term characterisation absent. Treat as experimental with the extract form carrying slightly more safety concerns than synthetic short-peptide form.
Where can I buy Chonluten?
Visit our vendor directory to find trusted sources for Chonluten.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.